ESG Trends in Pharmaceutical Industry

Table of Contents

Chapter 1 Introduction

• 1.1 What is Environmental, Social and Governance (ESG) Compliance?
• 1.2 Study Goals and Objectives
• 1.3 Reasons for Doing This Study
• 1.4 Scope of Report
• 1.5 Intended Audience
• 1.6 Information Sources
• 1.7 Analyst's Credentials
• 1.8 BCC Custom Research
• 1.9 Related BCC Research Reports

Chapter 2 Overview of the Pharmaceutical Industry

• 2.1 Introduction
• 2.2 Pharmaceutical Industry Supply Chain
  • 2.2.1 Manufacturing
  • 2.2.2 Distribution
  • 2.2.3 Providers
  • 2.2.4 Customers and Patients
• 2.3 ESG Deterrents in the Pharmaceutical Supply Chain

Chapter 3 Environmental Impact of the Pharmaceutical Industry

• 3.1 Introduction
• 3.2 Major Causes of Pharmaceutical Pollution
  • 3.2.1 Drug Use, Ingestion and Disposal
  • 3.2.2 Healthcare Institutions
  • 3.2.3 Drug Manufacturers
  • 3.2.4 Agriculture and Argo-Products
  • 3.2.5 Local Pharmaceutical Use and Disposal in Humans
• 3.3 Impact of Pharmaceutical Pollution
  • 3.3.1 Effects on Aquatic Life and Fish
  • 3.3.2 Disrupting Normal Sewerage Process Operations
  • 3.3.3 Drinking Water Impact
  • 3.3.4 Long-Lasting Effects on the Environment
  • 3.3.5 Antibiotic Resistance
  • 3.3.6 Impact on Wildlife
• 3.4 Growing Focus on Scope 3 Emissions
  • 3.4.1 Case Study on Pharmaceutical Pollution

Chapter 4 ESG in the Pharmaceutical Industry

• 4.1 Introduction to ESG
• 4.2 Increasing Adoption of ESG across Various Industries
• 4.3 ESG Proposition in Five Critical Ways
• 4.4 ESG Performance in the Pharmaceutical Industry
• 4.5 Surge in Investment in ESG in the Pharmaceutical Industry
• 4.6 ESG Investments by Key Players
• 4.7 Companies Incorporating ESG into Their Value Chains
  • 4.7.1 Biogen
  • 4.7.2 Collaboration between Novartis and GSK in Africa
  • 4.7.3 Amgen
  • 4.7.4 Enabler

Chapter 5 Market Dynamics

• 5.1 Macroeconomic Trends in the Market for ESG in the Pharmaceutical Industry
  • 5.1.1 Climate Change
  • 5.1.2 Medication Access in Underdeveloped Nations
  • 5.1.3 Drug Pricing and Gouging
• 5.2 ESG-Related Drivers of the Pharmaceutical Industry
• 5.3 ESG-Related Challenges for Pharmaceutical Industry
• 5.4 ESG-Related Opportunities in the Pharmaceutical Industry

Chapter 6 Appendix: Acronyms

List of Tables

• Table 1 : Net-Zero GHG Commitments by Major Life Sciences Companies
• Table 2 : Environmental, Social and Governance Factors in the Pharmaceutical Industry
• Table 3 : ESG Factors in the Pharmaceutical Industry
• Table 4 : Key Environmental, Social and Governance Issues in the Pharmaceutical Industry
• Table 5 : ESG Ranking of Pharmaceutical Industry Players, 2022
• Table 6 : Acronyms Used in This Report

List of Figures

• Figure 1 : Global Market Shares of the Pharmaceutical Industry, by Region, 2021
• Figure 2 : Top 10 Global Pharmaceutical Companies, by Revenue, 2021
• Figure 3 : Pharmaceutical Supply Chain
• Figure 4 : Level of Adoption of ESG across All Industries
• Figure 5 : Level of Adoption of ESG across All Industries by Region, 2021 and 2022